Biotechnology Assets S.A. (BST) — Cash Flow Quality Index
Biotechnology Assets S.A. (BST) has a Cash Flow Quality Index of -0.32x as of June 2023. Operating cash flow of €-935.60K is below net income of €2.95 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BST cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Biotechnology Assets S.A. Cash Flow Quality Index (2014–2023)
Historical Cash Flow Quality Index for Biotechnology Assets S.A. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Biotechnology Assets S.A. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Biotechnology Assets S.A. (2014–2023)
Year-by-year earnings quality comparison for Biotechnology Assets S.A.. For live market cap and the full company financial profile, see how much is Biotechnology Assets S.A. worth.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.02x | €47.74K | €2.32 Million | ▲ +105.1% |
| 2014 | -0.40x | €-303.79K | €756.27K | — |